Learning Objectives:

1. To review the current data on the risk of cardiovascular disease associated with tofacitinib 

2. To learn about the new data about tofacitinib based on this study and how it could be applied to the clinical setting


Session date: 
03/21/2023 - 9:30am to 10:30am CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kichul Ko, M.D.